Postal survey of physicians and laboratories: Practices and perceptions of molecular oncology testing

by Miller, Fiona A, Krueger, Paul, Christensen, Robert J, Ahern, Catherine, Carter, Ronald F, Kamel-Reid, Suzanne
Published 2009

Testing ERBB2 p.L755S kinase domain mutation as a druggable target in a patient with advanced colorectal cancer

by Aung, Kyaw L., Stockley, Tracy L., Serra, Stefano, Kamel-Reid, Suzanne, Bedard, Philippe L., Siu, Lillian L.
Published 2016

mRNA transcript quantification in archival samples using multiplexed, color-coded probes

by Reis, Patricia P, Waldron, Levi, Goswami, Rashmi S, Xu, Wei, Xuan, Yali, Perez-Ordonez, Bayardo, Gullane, Patrick, Irish, Jonathan, Jurisica, Igor, Kamel-Reid, Suzanne
Published 2011

The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of...

by Chau, Nicole G, Perez-Ordonez, Bayardo, Zhang, Katherine, Pham, Nhu-An, Ho, James, Zhang, Tong, Ludkovski, Olga, Wang, Lisa, Chen, Eric X, Tsao, Ming-Sound, Kamel-Reid, Suzanne, Siu, Lillian L
Published 2011

Recurrent genomic alterations in sequential progressive leukoplakia and oral cancer: drivers of oral tumorigenesis?

by Cervigne, Nilva K., Machado, Jerry, Goswami, Rashmi S., Sadikovic, Bekim, Bradley, Grace, Perez-Ordonez, Bayardo, Galloni, Natalie Naranjo, Gilbert, Ralph, Gullane, Patrick, Irish, Jonathan C., Jurisica, Igor, Reis, Patricia P., Kamel-Reid, Suzanne
Published 2014

A gene signature in histologically normal surgical margins is predictive of oral carcinoma recurrence

by Reis, Patricia P, Waldron, Levi, Perez-Ordonez, Bayardo, Pintilie, Melania, Galloni, Natalie Naranjo, Xuan, Yali, Cervigne, Nilva K, Warner, Giles C, Makitie, Antti A, Simpson, Colleen, Goldstein, David, Brown, Dale, Gilbert, Ralph, Gullane, Patrick, Irish, Jonathan, Jurisica, Igor, Kamel-Reid, Suzanne
Published 2011

A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors

by Diaz-Padilla, Ivan, Hirte, Hal, Oza, Amit M., Clarke, Blaise A., Cohen, Brenda, Reedjik, Michael, Zhang, Tong, Kamel-Reid, Suzanne, Ivy, S. Percy, Hotte, Sebastien J., Razak, Albiruni A. R., Chen, Eric X., Brana, Irene, Wizemann, Monika, Wang, Lisa, Siu, Lillian L., Bedard, Philippe L.
Published 2013

A window of opportunity study of potential tumor and soluble biomarkers of response to preoperative erlotinib in early stage non-small cell lung cancer

by Sacher, Adrian G., Le, Lisa W., Lara-Guerra, Humberto, Waddell, Thomas K., Sakashita, Shingo, Chen, Zhuo, Kim, Lucia, Zhang, Tong, Kamel-Reid, Suzanne, Salvarrey, Alexandra, Darling, Gail, Yasufuku, Kazuhiro, Keshavjee, Shaf, de Perrot, Marc, Shepherd, Frances A., Liu, Geoffrey, Tsao, Ming Sound, Leighl, Natasha B.
Published 2016

Clinical impact of mutation fraction in epidermal growth factor receptor mutation positive NSCLC patients

by Martin, Petra, Shiau, Carolyn J, Pasic, Maria, Tsao, Ming, Kamel-Reid, Suzanne, Lin, Stephanie, Tudor, Roxana, Cheng, Susanna, Higgins, Brian, Burkes, Ronald, Ng, Matilda, Arif, Saroosh, Ellis, Peter M, Hubay, Stacy, Kuruvilla, Sara, Laurie, Scott A, Li, Jing, Hwang, David, Lau, Anthea, Shepherd, Frances A, Le, Lisa W, Leighl, Natasha B
Published 2016

Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial

by Stockley, Tracy L., Oza, Amit M., Berman, Hal K., Leighl, Natasha B., Knox, Jennifer J., Shepherd, Frances A., Chen, Eric X., Krzyzanowska, Monika K., Dhani, Neesha, Joshua, Anthony M., Tsao, Ming-Sound, Serra, Stefano, Clarke, Blaise, Roehrl, Michael H., Zhang, Tong, Sukhai, Mahadeo A., Califaretti, Nadia, Trinkaus, Mateya, Shaw, Patricia, van der Kwast, Theodorus, Wang, Lisa, Virtanen, Carl, Kim, Raymond H., Razak, Albiruni R. A., Hansen, Aaron R., Yu, Celeste, Pugh, Trevor J., Kamel-Reid, Suzanne, Siu, Lillian L., Bedard, Philippe L.
Published 2016